Medscape23h
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
eLife4d
Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of Osteoarthritis
This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...
Petvivo Signs Exclusive Sales And Marketing Agreement With Vetstem For Preciseprp® Canine And Equine Products
This is a game changer for veterinarians and their ability to treat their patients with PRP”, said Mike Eldred, PetVivo Board Member.“This innovative, and FDA reviewed product, will be a great ...
Investopedia6d
What Is Joint Tenancy in Property Ownership?
Joint tenancy is a legal form of property ownership where two or more individuals hold equal rights and obligations to a property. This arrangement can be made by married or unmarried couples ...
Business Wire21h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
BMJ4d
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
Methods Early, biologic and MTX-naive RA patients (N=395) were evenly randomised to open-label adalimumab (40 mg every other ... proportion of patients achieving the primary endpoint, 28-joint count ...